Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden

(2009) O. Landgren et al.   BLOOD

Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study

(2009) S. Y. Kristinsson et al.   HAEMATOLOGICA

Survival Effect of Venous Thromboembolism in Patients With Multiple Myeloma Treated With Lenalidomide and High-Dose Dexamethasone

(2009) Maurizio Zangari et al.   JOURNAL OF CLINICAL ONCOLOGY

Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma

(2008) S. Y. Kristinsson et al.   BLOOD

Thalidomide and rituximab in Waldenstrom macroglobulinemia

(2008) S. P. Treon et al.   BLOOD

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden

(2008) S. Y. Kristinsson et al.   BLOOD

Lenalidomide and Rituximab in Waldenstrom's Macroglobulinemia

(2008) S. P. Treon et al.   CLINICAL CANCER RESEARCH

Arterial and Venous Thrombotic Complications with Thalidomide in Multiple Myeloma

(2007) Salam Alkindi et al.   ARCHIVES OF MEDICAL RESEARCH